| Description | Dacetuzumab (SGN-40), a humanized IgG1 anti-CD40 monoclonal antibody, exhibits anti-lymphoma activity by inducing tumor cell death through immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). It is utilized in research on multiple myeloma [1]. |
| molecular weight | N/A |
| CAS | 880486-59-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |